Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.


OBJECTIVES Tenofovir disoproxil fumarate (TDF) is active against hepatitis B virus (HBV) and HIV. However, the long-term efficacy of tenofovir disoproxil fumarate (TDF) is not well known and the appearance of resistance is a major concern. We have studied the efficacy of TDF against HBV in patients treated at an Infectious Diseases Unit. METHODS We… (More)
DOI: 10.1111/j.1468-1293.2008.00683.x